Moderately to Severely Active Crohn Disease
1 clinical trials · Condition
◉ Watch Moderately to Severely Active Crohn Disease
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease (NCT06456593) | Abivax S.A. | 2024-10-30 |
Track Moderately to Severely Active Crohn Disease automatically
Every clearance here is in the API, with alerts when new ones post.